Benz Advisory
Share:
Subscribe:
news.cision.com
/
Benz Advisory
/
Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform
/
Creoptix Logo
1 of 3
Creoptix Logo
Tue, Jan 12, 2021 09:05 CET
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
Creoptix launches waveRAPID[®] – a new and faster way of measuring kinetics to accelerate drug discovery
Tue, Feb 02, 2021 09:14 CET
